Naproxen Tablet, Delayed Release
Product Images NDC 66267-373

4 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 66267-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (0778e9f1 B341 448c Ba26 Cfa4370e8123 01)

Description (0778e9f1 B341 448c Ba26 Cfa4370e8123 01)
Chemical structure of Naproxen showing its molecular formula C14H14O3 and molecular weight 230.26. The structure includes annotations for functional groups and stereochemistry.*
FDA Label Image

Clinical Pahrmacology (0778e9f1 B341 448c Ba26 Cfa4370e8123 02)

Clinical Pahrmacology (0778e9f1 B341 448c Ba26 Cfa4370e8123 02)
A data table comparing pharmacokinetic parameters for Naproxen delayed-release tablets and Naproxen tablets, both 500 mg taken twice daily. It shows mean values and coefficients of variation for maximum concentration (Cmax), time to maximum concentration (Tmax), and area under the curve from 0 to 12 hours (AUC0-12).*
FDA Label Image

Dosage And Administration (0778e9f1 B341 448c Ba26 Cfa4370e8123 03)

Dosage And Administration (0778e9f1 B341 448c Ba26 Cfa4370e8123 03)
A text panel for Naproxen delayed-release tablets showing available strengths of 375 mg or 500 mg and a dosage frequency indication of twice daily.*
FDA Label Image

66267 373 20

66267 373 20
NuCare Pharmaceuticals Naproxen 500 mg delayed-release tablets label. This label includes the product name Naproxen 500mg, dosage form as enteric-coated delayed-release tablets, and a count of 20 tablets. It shows the NDC number 66267-373-20, manufacturing by Invagen Pharmaceuticals, Inc., and warnings to keep out of reach of children, as well as storage instructions at controlled temperature 68-77°F. Additional product details include the capsule-shaped white tablet description with debossed '111'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.